# US 6,727,065 B2 · Methods of use of semiconductor nanocrystal probes for treating a material

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,727,065 B2
- Document ID: US6727065B2
- Status: Granted
- Kind: B2
- Application number: 09/781,621
- Filed: 2001-02-12
- Published: 2002-06-13
- Granted: 2004-04-27
- Earliest claimed: 1997-11-25
- Assignees: The Regents of the University of California
- Inventors: Shimon Weiss; Marcel Bruchez; Paul Alivisatos
- Web page: https://patentgrep.com/patent/US6727065B2

## CPC

- H10H 20/013: {having light-emitting regions comprising only Group III-V materials}
- B82Y 15/00: Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
- C09K 11/025: {non-luminescent particle coatings or suspension media}
- C09K 11/565: {with zinc cadmium}
- C09K 11/883: {with zinc or cadmium}
- C09K 11/89: containing mercury
- C09K 11/892: {Chalcogenides}
- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- G01N 33/533: with fluorescent label
- G01N 33/542: with steric inhibition or signal modification, e.g. fluorescent quenching
- G01N 33/54373: {involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings}
- G01N 33/588: {with semiconductor nanocrystal label, e.g. quantum dots}
- H10H 20/012: {having light-emitting regions comprising only Group II-IV materials}
- C12Q 2563/107: fluorescence
- Y10T 436/141111: Diverse hetero atoms in same or different rings [e.g., alkaloids, opiates, etc.]
- Y10T 436/142222: Hetero-O [e.g., ascorbic acid, etc.]
- H10H: INORGANIC LIGHT-EMITTING SEMICONDUCTOR DEVICES HAVING POTENTIAL BARRIERS
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- C09K: MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

A semiconductor nanocrystal compound and probe are described. The compound is capable of linking to one or more affinity molecules. The compound comprises (1) one or more semiconductor nanocrystals capable of, in response to exposure to a first energy, providing a second energy, and (2) one or more linking agents, having a first portion linked to one or more semiconductor nanocrystals and a second portion capable of linking to one or more affinity molecules. One or more semiconductor nanocrystal compounds are linked to one or more affinity molecules to form a semiconductor nanocrystal probe capable of bonding with one or more detectable substances in a material being analyzed, and capable of, in response to exposure to a first energy, providing a second energy. Also described are processes for respectively: making the semiconductor nanocrystal compound; making the semiconductor nanocrystal probe; and treating materials with the probe.

## Claims

### Claim 1

A process for treating a material using one or more semiconductor nanocrystal probes to determine the presence of one or more detectable substances in said material which comprises:
a) contacting said material with one or more semiconductor nanocrystal probes, said one or more semiconductor nanocrystal probes each comprising:
i) one or more semiconductor nanocrystals, each capable of, in response to exposure to a first energy, providing a second energy;
ii) one or more first linking agents, at least one of said one or more first linking agents comprising a three-dimensional shaped structure capable of having linked thereto said one or more semiconductor nanocrystals, each of said one or more first linking agents capable of linking to:
1) one or more second linking agents; or
2) one or more affinity molecules; and
iii) one or more affinity molecules linked either to said one or more second linking agents or to said one or more first linking agents, each of said one or more affinity molecules capable of selectively bonding to said one or more detectable substances;
b) exposing said one or more semiconductor nanocrystal probes to said first energy; and
c) detecting said second energy provided by said one or more semiconductor nanocrystals in said one or more semiconductor nanocrystal probes bonded to said one or more detectable substances in said material.

### Claim 2 (depends on 1)

The process for treating material of claim 1, wherein said three dimensional shaped structure is linked to two or more of said semiconductor nanocrystals.

### Claim 3 (depends on 2)

The process for treating a material of claim 2, wherein said one or more semiconductor nanocrystal probes comprises two or more of said semiconductor nanocrystals probes.

### Claim 4 (depends on 3)

The process for treating a material of claim 3, wherein each of said two or more semiconductor nanocrystal probes comprises:
(a) a semiconductor nanocrystal capable of providing a second energy that is the same as that of the semiconductor nanocrystals of which the others of said two or more semiconductor nanocrystal probes are comprised;
(b) a semiconductor nanocrystal capable of providing a second energy that is distinguishable from that of the semiconductor nanocrystals of which at least one of the others of said two or more semiconductor nanocrystal probes are comprised; or
(c) a combination of semiconductor nanocrystals capable of providing a second energy that is the same as or that is distinguishable from that of the semiconductor nanocrystals of which at least one of the others of said two or more semiconductor nanocrystal probes are comprised.

### Claim 5 (depends on 1)

The process for treating a material of claim 1, wherein said second energy provided by said two or more semiconductor nanocrystals linked to said three dimensional shaped structure comprises one or more detectable signals.

### Claim 6 (depends on 5)

The process for treating a material of claim 5, wherein said one or more detectable signals comprises two or more detectable signals.

### Claim 7 (depends on 6)

The process for treating a material of claim 6, wherein each of said two or more detectable signals are distinguishable.

### Claim 8 (depends on 6)

The process for treating a material of claim 6, wherein each of said two or more detectable signals are spectrally distinguishable.

### Claim 9 (depends on 1)

The process for treating a material of claim 1, wherein said three-dimensional shaped structure is linked by covalently bonding to said one or more semiconductor nanocrystals.

### Claim 10 (depends on 1)

The process for treating a material of claim 1, wherein said three-dimensional shaped structure is linked by adherence to said one or more semiconductor nanocrystals.

### Claim 11 (depends on 1)

The process for treating a material of claim 1 wherein said three-dimensional shaped structure is linked by embedding to said one or more semiconductor nanocrystals.

### Claim 12 (depends on 1)

The process for treating a material of claim 1, wherein said three-dimensional shaped structure further comprises one or more organic materials.

### Claim 13 (depends on 1)

The process for treating a material of claim 1, wherein said three-dimensional shaped structure further comprises one or more inorganic materials.

### Claim 14 (depends on 1)

The process for treating a material of claim 1, wherein said three-dimensional shaped structure comprises a porous solid structure which encapsulates said one or more semiconductor nanocrystals.

### Claim 15 (depends on 1)

The process for treating a material of claim 1, wherein said three-dimensional shaped structure comprises a non-porous solid structure which encapsulates said one or more semiconductor nanocrystals.

### Claim 16 (depends on 1)

The process for treating a material of claim 1, wherein said three-dimensional shaped structure comprises a hollow structure which encapsulates said one or more semiconductor nanocrystals.

### Claim 17 (depends on 1)

The process for treating a material of claim 1, wherein said three-dimensional shaped structure comprises a spherically shaped structure.

### Claim 18 (depends on 1)

The process for treating a material of claim 1, wherein said three-dimensional shaped structure comprises two or more substructures wherein each substructure comprises one or more identical semiconductor nanocrystals.

### Claim 19 (depends on 18)

The process for treating a material of claim 18, wherein said two or more substructures each comprise one layer in a layered structure.

### Claim 20 (depends on 1)

The process for treating a material of claim 1, wherein said three dimensional shaped structure comprises a medium transparent to:
i) said first energy to which said one or more semiconductor nanocrystals is exposed; and
ii) said second energy provided by said semiconductor nanocrystals in response to said exposure to said first energy.

### Claim 21 (depends on 1)

The process for treating a material of claim 1, wherein each of said one or more affinity molecules comprises a protein, a molecule of one or more strands of nucleic acid, a polysaccharide or a small molecule.

### Claim 22 (depends on 21)

The process for treating a material of claim 21, wherein each of said one or more affinity molecules comprises a molecule of one or more strands of nucleic acid.

### Claim 23 (depends on 22)

The process for treating a material of claim 22, wherein each of said one or more detectable substances comprises a molecule of one or more strands of nucleic acid with which said probe bonds.

### Claim 24 (depends on 21)

The process for treating a material of claim 21, wherein each of said one or more affinity molecules comprises a protein.

### Claim 25 (depends on 24)

The process for treating a material of claim 24, wherein the protein is an antibody.
